nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-06A9DEEE·Framework v5.9·Pipeline v0.4·Evaluated 08 Oct 2026·OECD: 3.1 Basic medicine·Subfield: Psychiatry and Mental health·Basis: Full text·Type: Prediction or prognostic modeling

Genetic investigation of non-affective psychosis and depression as causal risk factors for dementia.

Escott-Price et al.Escott-Price, Simmonds, Owen et al.·2026·BMJ mental health·10.1136/bmjment-2025-302424 ↗

Primary claim

Dementia cases with prior non-affective psychosis or depression had lower AD genetic liability than those without a psychiatric history

Supported · case-only PRS associations support the direction, with limited precision for psychosis and no direct causal identification
In brief

A creative case-only genetic analysis identifies lower Alzheimer’s liability after psychiatric illness, but its causal conclusion exceeds what the design can establish.

ReliabilityNo concerns4 of 4 checks completeSee what was checked ↓
Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

BACKGROUND: Major psychiatric disorders are associated with increased risk of dementia but establishing whether psychiatric disorders causally increase dementia risk is challenging because dementia pathology can precede clinical diagnosis by decades. Prodromal psychiatric symptoms may arise long before cognitive decline, leaving open the possibility of reverse causation.

OBJECTIVE: We aimed to determine whether non-affective psychosis or depression credibly causally influence dementia risk using a design robust to reverse causation. We tested whether people with psychiatric disorders who later develop dementia show reduced genetic liability to Alzheimer's disease (AD) compared with dementia cases without such history.

METHODS: We compared AD genetic liability, measured by polygenic risk scores (PRS) among dementia cases (N=7936) with and without prior non-affective psychosis (N=56) or depression (N=937) in the UK Biobank. We examined whether schizophrenia or major depressive disorder (MDD) PRS correlates with dementia liability to assess whether shared trait liability contributes to the association.

FINDINGS: Dementia cases with prior non-affective psychosis or depression had lower AD genetic liability than those without a psychiatric history (psychosis: B=-0.29, 95% CI (-0.54 to -0.05), p=0.036; depression: B=-0.12, 95% CI (-0.18 to -0.05), p=0.0004), which is inconsistent with the hypothesis that the association between psychiatric disorders in dementia is explained by prodromal dementia effects. After excluding people with psychiatric diagnoses, neither schizophrenia nor MDD liability showed the negative correlations with AD liability in people with dementia expected if trait liability to those disorders per se contributed to dementia risk. Our findings instead are consistent with exposure to the disorders themselves as being associated with dementia.

CONCLUSIONS: Our findings are consistent with the hypothesis that psychiatric disorders are associated with increased vulnerability to dementia.

CLINICAL IMPLICATIONS: Identification of potentially modifiable mechanisms for the association and optimal management of non-affective psychosis and depression may help reduce long-term dementia risk and inform prevention strategies.

Key Claims

Primary finding · Supported

Dementia cases with prior non-affective psychosis or depression had lower AD genetic liability than those without a psychiatric history

Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

case-only PRS associations support the direction, with limited precision for psychosis and no direct causal identification

Abstract, Findings
Quote verified
Secondary · Tentative

The association cannot be fully explained by psychiatric disorders manifesting as prodromal symptoms of dementia

the design challenges a simple prodromal account but cannot exclude prodromal effects across heterogeneous dementia pathways

Discussion, concluding paragraph
Quote verified
Secondary · Tentative

These findings imply that the association between the psychiatric disorders and dementia cannot be attributed to shared trait liability to both sets of disorders.

the inference rests on non-significant PRS correlations and PRS measures only part of underlying liability

Discussion, paragraph 2
Quote verified
Secondary · Tentative

our findings point to the important conclusion that increased rates of dementia in those with psychotic disorders and depression are a consequence of manifesting those disorders

causal consequence is not identified by the observational case-only comparison and acknowledged alternatives remain

Discussion, concluding paragraph
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Creative test of reverse causation

The Objective derives a specific liability-threshold prediction and tests it by comparing Alzheimer’s PRS among dementia cases with and without prior psychosis or depression.

↳ Introduction, Objective; Methods, Statistical Analysis

#methodological rigour

Multiple robustness analyses reported

The primary associations are examined using five-year exclusions, alternative age-at-first-record cut-offs, a stricter comparator group, and adjustment for several measured dementia risk factors.

↳ Results, Non-Affective Psychosis and Dementia; Depression and Dementia; Mediators and Confounders

#positioning

Relevant literature and limitations engaged

The paper discusses observational, MR, genetic-correlation, and recent UK Biobank evidence and explicitly addresses diagnostic timing, dementia subtypes, medication, and unmeasured exposures.

↳ Introduction; Discussion and Limitations

Limitations

#reporting

Causal conclusion exceeds the design

A case-only association between psychiatric history and Alzheimer’s PRS cannot establish that manifesting the disorder caused subsequent dementia, yet that conclusion is stated in the study summary and final paragraph.

↳ What This Study Adds; Discussion, concluding paragraph

#methodological rigour

Small and selected psychosis comparison

The primary psychosis analysis includes 56 exposed dementia cases after age-at-first-record exclusions, producing an imprecise estimate and limiting robustness and transferability.

↳ Results, Non-Affective Psychosis and Dementia; Discussion, Limitations

#positioning

Alternative mechanisms remain unresolved

The paper acknowledges that treatment effects, incompletely measured exposures, and unidentified risk factors cannot be excluded, which conflicts with its categorical causal framing.

↳ Discussion, Limitations and concluding paragraph

Does this match your read? Add your assessment ↓

Nabu Commentary

The disorder-specific PRS comparison and consistent depression result make a genuine contribution to the reverse-causation debate, supported by several timing and covariate sensitivity analyses. The methodological score remains moderate because the analysis conditions on dementia status, combines heterogeneous dementia types, and includes only 56 psychosis cases in the primary contrast. The presentation is structurally clear, but the What This Study Adds box and conclusion convert indirect compatibility evidence into a causal assertion. That assertion also conflicts with the Discussion’s acknowledgement that treatment, environmental exposures, and other unidentified factors cannot be excluded.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.0±0.2

Contribution
3.5

The liability-threshold comparison is a meaningful disorder-specific extension of prior UK Biobank work and addresses reverse causation from a useful angle. Its advance remains bounded because the design supplies indirect evidence rather than a causal effect estimate.

Introduction, Objective; Discussion, comparison with prior UK Biobank study

Our effect sizes were stronger

Methodological Rigour
2.8

The paper reports external GWAS sources, PRS construction, ancestry adjustment, confidence intervals, and several timing and covariate sensitivity analyses. Conditioning on dementia cases, combining dementia subtypes, the psychosis subgroup of 56, and reliance on null PRS correlations leave material uncertainty about the causal interpretation.

Methods, PRS Calculation and Statistical Analysis; Results; Discussion, Limitations

we retained 56 and 7731 people with/without psychosis

Reporting
3.2

The progression from the liability-threshold rationale through the primary and follow-up analyses is easy to follow. Reporting is reduced because categorical causal language in the study summary and conclusion is stronger than the case-only evidence supports.

What This Study Adds; Discussion, concluding paragraph

a consequence of manifesting those disorders

Positioning
2.8

The paper engages observational, genetic-correlation, Mendelian-randomisation, and closely related UK Biobank evidence, and it identifies several consequential limitations. The conclusion nevertheless contradicts its acknowledgement that direct effects cannot be separated from treatment, environmental, or unidentified factors.

Introduction; Discussion, Limitations and concluding paragraph

We cannot distinguish between direct effects

Reliability

No concerns4 of 4 checks


Results checkClean

The reported numbers and statistics are consistent with the stated results.

Reporting and transparencyClean

No text-grounded reporting or transparency concern was retained from the supplied concerns.

Ethics approval: declared · Data availability: declared · Code availability: not stated

Reference IntegrityClean

30 references in manuscript 30 of 30 checkable references found in an index

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Neurological · Alzheimer's disease and other dementias
Type of advanceConceptual
Route to useNamed
AdvanceExtends
BeneficiariesLarge
CitationsToo early
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessPiloted
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The primary claim is demonstrated once in a single large cohort (UK Biobank) with internal sensitivity analyses, but no independent cohort or external dataset confirms the finding.

From the paper
“Policymakers may consider integrating psychiatric care with dementia risk assessment and long-term prevention planning.”

The paper names policymakers and clinicians as actors who would use these findings for dementia-prevention strategies and integrated psychiatric care, without specifying the exact decision setting or implementation steps.

Pathway

Policymakers and clinicians managing patients with psychosis or depression could integrate dementia risk monitoring and prevention strategies into psychiatric care.

Barrier

The modifiable mechanisms linking psychiatric disorders to dementia, including treatment effects and environmental exposures, remain unidentified and require further investigation.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Effect of intensive blood pressure control on cognitive outcomes and brain structures in adults with type 2 diabetes: prespecified analysis of secondary outcomes of BPROAD randomised controlled trial

    Wang, Xu, Xu, et al. · 2026 · Clinical medicine

    Primary claim

    no statistically significant difference in incidence of a composite of all cause dementia or mild cognitive impairment was observed among adults with type 2 diabetes receiving standard treatment of SBP and intensive treatment

    Well-supported
    Evidence Score
    4.1±0.1
    Reliability
    Caveats
  2. Smoking and dementia risk: an updated systematic review and meta-analysis of 61 prospective cohort studies and implications for tobacco control

    Mario Siervo, Jacob Brain, Sarah Beasley, et al. · 2026 · Health sciences

    Primary claim

    Current smoking was associated with increased risk of all-cause dementia (RR 1.31 [95% CI 1.23–1.39]; number of studies (k) = 39), Alzheimer's disease (1.40 [1.08–1.80]; k = 15), and vascular dementia (1.52 [1.20–1.93]; k = 9).

    Supported
    Evidence Score
    3.3±0.2
    Reliability
    Caveats
  3. Decreased awareness of cognitive decline is associated with multimodal Alzheimer's disease biomarkers in cognitively unimpaired individuals

    2026 · Clinical medicine

    Primary claim

    decreased ACD was associated with greater AD pathological burden

    Supported
    Evidence Score
    3.2±0.2
    Reliability
    Caveats

How the rubric works →